Reports Q1 revenue $228M, consensus $215.1M. "We are pleased to report results for the second quarter that exceeded the high-end of our guidance. Demand for our products was strong during the quarter. Revenue growth for the Industrial segment exceeded our expectations, while Medical segment revenue growth was as expected," said Sunny Sanyal, CEO. "We are encouraged by the demand levels we are seeing, and we anticipate our growth to remain solid in the second half of the fiscal year."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on VREX:
